Berger Dietmar bought GILD
March 10, 2026 · Form 4 insider transaction
Berger Dietmar bought 31,475 shares of Gilead Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,475
Price
$0.00
Total value
N/A
InsiderBerger Dietmar
Role—
CompanyGilead Sciences, Inc. (GILD)
SecurityNon-qualified Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 10, 2026
Filing dateMarch 12, 2026
Shares owned after31,475
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options have a four-year vesting schedule. 25% of the options vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.